MatriSys Bioscience
PrivateLast Round
Series A
Jul 15, 2022
Total Funding Raised
$14.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MatriSys Bioscience operates in Healthcare & Life Sciences and is based in La Jolla, California. Its latest recorded funding round was a Series A round in July 2022.
MatriSys Bioscience is a biotechnology company that develops microbiome-based therapeutics for the treatment of chronic skin diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MatriSys Bioscience Comparables
Compare MatriSys Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AOBiome Therapeutics Inc. | 88% | |
| Alphyn Biologics, Inc. | 82% | |
| ResVita Bio | 81% |
For institutional investors. Book with your work email.
MatriSys Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 15, 2022 | ||||
| Debt | Mar 11, 2021 | ||||
| VC Round | Mar 11, 2021 | ||||
| Convertible Debt | Jan 5, 2017 |
For institutional investors. Book with your work email.
MatriSys Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | VC Round |
| Mesa Verde Venture Partners | VC Round, Series A |
| ALMA Life Sciences | Series A |
| TCA Venture Group | Series A, Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 117% MoM.
- Feb 2, 2026
Monthly visitors increased 63% MoM.
For institutional investors. Book with your work email.
MatriSys Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MatriSys Bioscience's valuation, stock price, and market status.
Is MatriSys Bioscience a public or private company?
MatriSys Bioscience is a private company.
What is the current stock price of MatriSys Bioscience?
MatriSys Bioscience is a private company, so its shares have no public market price. Caplight tracks MatriSys Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MatriSys Bioscience worth (valuation)?
Valuation information for MatriSys Bioscience is not publicly available.
Can I buy MatriSys Bioscience stock?
MatriSys Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MatriSys Bioscience's last funding round?
MatriSys Bioscience's most recent funding round was Series A on July 15, 2022.
Who are the main investors in MatriSys Bioscience?
Key investors in MatriSys Bioscience include National Institute of Allergy and Infectious Diseases, TCA Venture Group.
Will MatriSys Bioscience IPO soon?
No public IPO plans have been announced for MatriSys Bioscience.
How can I track MatriSys Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in MatriSys Bioscience's shares on secondary markets.